about
Cerebral hemorrhages in CADASIL: report of four cases and a brief review.Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A reviewSyncope and Epilepsy coexist in 'possible' and 'drug-resistant' epilepsy (Overlap between Epilepsy and Syncope Study - OESYS)Stroke recurrence in an elderly CADASIL patient on aspirin discontinuation due to severe auto-immune thrombocytopenia.Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers-The VMCI-Tuscany Study: Rationale, Design, and Methodology.Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience.APOE ɛ2 is associated with white matter hyperintensity volume in CADASILPsychiatric disturbances in CADASIL: a brief review.The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trial.Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study.Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): a pragmatic randomised trial.Heterozygous mutations of HTRA1 gene in patients with familial cerebral small vessel disease.Pregnancy in CADASIL.Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients.Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients.Response to letter regarding article, “The cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy scale. A screening tool to select patients for NOTCH3 gene analysis”.Letter by Pescini et al regarding article, "Peripheral artery disease as a manifestation of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and practical implications".A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient.White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study.First report of a Romanian CADASIL patient following immigration to Italy.Operationalizing mild cognitive impairment criteria in small vessel disease: the VMCI-Tuscany Study.Location, number and factors associated with cerebral microbleeds in an Italian-British cohort of CADASIL patients.The Florence VAS-COG clinic: a model for the care of patients with cognitive and behavioral disturbances consequent to cerebrovascular diseases.APOE and AGT in the Finnish p.Arg133Cys CADASIL population.White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study.Facial affect recognition in CADASIL patients.Clinical, familial, and neuroimaging features of CADASIL-like patients.Diffusion Tensor Imaging to Map Brain Microstructural Changes in CADASIL.The VAS-COG clinic: an out-patient service for patients with cognitive and behavioral consequences of cerebrovascular diseases.Familial cerebral cavernous malformation: report of a further Italian family.Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL.Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview.First report of a pathogenic mutation on exon 24 of the NOTCH3 gene in a CADASIL family.Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: results from the MIcrovascular LEukoencephalopathy Study (MILES).The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: a screening tool to select patients for NOTCH3 gene analysis.Stroke unit care in clinical practice: an observational study in the Florence center of the European Registers of Stroke (EROS) Project.Postpartum psychiatric disturbances as an unrecognized onset of CADASIL.Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients.
P50
Q30620885-7FEAC087-8A6D-4D37-A4CE-461F00350F7BQ30968601-0A01AB59-C419-4598-A445-297986D927FAQ33168318-B7076540-4992-40EE-B9A1-115B69F898FBQ33388829-B6D2768A-BBD7-4D13-B8C2-3A6A54B1CE85Q35895842-20D5ED39-5145-4FB8-A08F-F565F0647EAFQ35973490-CBB269B0-6673-42F3-A517-DF05A489FD03Q36593238-BB044C4E-34F6-42EB-9AA7-B42D8D2CAD55Q37126773-2A9970B8-79DC-4093-B623-A73D100A9F12Q38357313-B4816E21-7287-45A3-8E21-B6D555B61605Q38424269-E6CF36E1-A7F1-4B8E-8130-A375EC960E2DQ38436418-2C053EDE-7EF3-4AC6-B9A5-209A55F2BE39Q38437964-05143593-3482-4A7B-B52D-0E9658FF9A6CQ38637727-D4055D81-634F-4866-AD71-202591A1DE0AQ38728301-8C59AFE7-C7A8-45FD-9CD0-0BED3AB43331Q38854066-6C8364FE-8CBB-4C26-9909-7243847F5E16Q39162475-61EB4520-3CC4-4F8E-A5FA-92FBA4C854A5Q43206146-A4DEF23A-7FD9-4C2A-A0E2-6E6A25D4FFD3Q44178728-82346C13-7819-4BE0-8367-89A7C970E2E5Q44673622-22E928DF-46C2-40DA-9AB0-41B40D52FC8AQ46894124-AB095444-9BC0-4044-A3AF-8AA33CEC7C5CQ48072123-391BEF49-CB92-4B4E-B123-5F52A7292B2DQ48091815-D1127A5E-6784-4ECC-8512-E7C7BA226E58Q48126640-29621E6C-D0BC-4CC0-8E28-344513779464Q48166053-0F49B211-2F82-482E-AEE3-CD26A04E3863Q48235238-89CD6E83-E170-4405-A995-7D13203D637CQ48257499-A31624D5-ABDB-4435-AB58-790AC5391926Q48456547-1425DE7B-9BD2-437A-BDC3-7180024DCFC8Q48584579-297DB6E5-60DA-4337-8D20-FDCDC0CFADC3Q48612790-20A1FBCA-72EC-4C9A-B935-6660665CE220Q48649629-9D1A5F92-B959-4DA1-9012-AD4CB06CB3BEQ48751323-BAEE80BC-CE58-4D74-9C52-3233E1D90509Q48773459-6121998C-B9A8-47C1-9C31-EB84DAEAC40CQ48883801-413CF832-2474-4051-9B0D-F834D1FE058CQ48887525-A98462BE-193D-4655-9A00-DA54EB28A1B9Q50265321-AABBBFE3-3A93-4EA1-BE57-EFEA3054AD37Q50891030-126EB954-3BC7-45E3-B70D-86D8828530DEQ51321267-80E6E2B8-7E22-48CC-B7FC-0BA80AB2516EQ51752087-ECD8D23E-5769-4001-BBE9-68F7A75D9D62Q51926983-18CE23A8-FBCD-4C1D-BFC3-5F9573BD3F26Q55284993-D598FE0C-4904-4927-88CF-0D8CB030BF53
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesca Pescini
@ast
Francesca Pescini
@en
Francesca Pescini
@es
Francesca Pescini
@nl
Francesca Pescini
@sl
type
label
Francesca Pescini
@ast
Francesca Pescini
@en
Francesca Pescini
@es
Francesca Pescini
@nl
Francesca Pescini
@sl
prefLabel
Francesca Pescini
@ast
Francesca Pescini
@en
Francesca Pescini
@es
Francesca Pescini
@nl
Francesca Pescini
@sl
P106
P1153
12792717400
P21
P31
P496
0000-0003-4565-5601